Window Tint Medical Exemption for Melanoma & Skin Cancer

Overview

Melanoma is the most serious form of skin cancer, responsible for the majority of skin-cancer deaths in the United States. The American Cancer Society estimates about 100,000 new cases of invasive melanoma per year, plus millions of non-melanoma skin cancers (basal-cell and squamous-cell carcinomas). For any patient with a personal or family history of melanoma — or a documented precursor lesion — UV avoidance is a lifelong clinical priority.

Cars are a significant and under-appreciated UVA source. A 2016 JAMA Ophthalmology study showed driver-side glass blocks only a median of 71% of UVA — compared to 96% for the front windshield. Multiple large epidemiological studies have documented that U.S. drivers have higher skin-cancer incidence on the left side of the body and face.

A window-tint medical exemption lets skin-cancer patients bring their vehicle up to the protection level their oncologist or dermatologist recommends. MyEyeRx connects you with an evaluating physician who can document the history and complete your state's paperwork within 24–48 hours.

How Melanoma / Skin Cancer Relates to Window Tint

UVA (315–400 nm) penetrates deeply into the dermis and drives melanoma mutagenesis through reactive oxygen species and direct DNA damage. Unlike UVB, UVA passes through most automotive side glass largely unattenuated.

Medical window tint films add a UV-absorbing layer that brings UVA transmission to under 1% — comparable to the windshield's native protection and aligned with dermatology-society recommendations.

Reducing cumulative UVA exposure is the primary clinical rationale for automotive UV protection in patients with a skin-cancer history. The evidence base comes from studies of pilots, truck drivers, and long-haul commuters, all of whom have measurably higher skin-cancer incidence on their "driver side."

Common Melanoma / Skin Cancer Symptoms That Qualify

The following symptoms are commonly associated with Melanoma & Skin Cancer and may contribute to your eligibility for a window-tint medical exemption. If you experience one or more of these — particularly while driving or exposed to sunlight — medical-grade tint can meaningfully reduce your trigger load.

• New or changing mole — asymmetry, border irregularity, color variation, diameter >6 mm, or evolving over time (ABCDE criteria)
• Non-healing sore, scab, or ulcer on sun-exposed skin
• Scaly, red, or rough patch (actinic keratosis — a melanoma/SCC precursor)
• Pearly, translucent, or bleeding bump (basal-cell carcinoma pattern)
• Persistent itching, burning, or tenderness of a skin lesion
• History of severe sunburns in childhood or adolescence
• Family history of melanoma — particularly in first-degree relatives
• Prior surgical excision of melanoma or non-melanoma skin cancer

Why Medical Window Tint Helps Melanoma / Skin Cancer

Medical-grade window tint is a recognized environmental control for Melanoma & Skin Cancer. It works by reducing the in-cabin light, UV, and glare load — the same triggers that worsen symptoms in everyday driving. Paired with your regular medical care, tint is a low-risk, evidence-based complement that your state formally recognizes with an exemption to its VLT statute.

• ✓ Blocks ~99% of UVA and UVB in-cabin, meeting dermatology-society UV-avoidance recommendations
• ✓ Reduces left-side UV exposure, which is statistically associated with higher skin-cancer incidence in U.S. drivers
• ✓ Provides passive, always-on protection that does not rely on sunscreen reapplication during the commute
• ✓ Covers the face, arms, and hands — the most common melanoma sites in drivers
• ✓ Protects passengers, including children and other family members with a melanoma or BCC history
• ✓ Lowers in-cabin temperature, indirectly reducing total sun exposure time (shorter cooldown periods at destinations)
• ✓ Supports long-term recurrence prevention — particularly important in the first five years after melanoma treatment

Clinical Context

A few nuances worth highlighting for Melanoma & Skin Cancer. These are the kinds of details your evaluating physician will look for in your records, and they often strengthen an exemption application when disclosed up-front.

• i The American Academy of Dermatology and the Skin Cancer Foundation both endorse UV-blocking window film as part of a comprehensive sun-protection program for skin-cancer patients.
• i Even in-situ or early-stage melanomas qualify — the exemption is indication-based, not severity-based.
• i Patients on immunosuppressants after organ transplant have 65–250× higher rates of squamous-cell carcinoma and also qualify under the same exemption pathway.
• i Co-occurring conditions (XP, albinism, vitiligo, porphyria) strengthen the documentation; list all of them in your consultation.

Melanoma / Skin Cancer and Driving Safety

Beyond symptom control, a melanoma / skin cancer-appropriate tint exemption is a legitimate driver-safety intervention. The same environmental factors that trigger symptoms also contribute to reduced attention, reflexive squinting, and delayed reaction time — all of which raise crash risk on daytime and night-time drives.

• Reduced glare lowers reflexive squinting and eye closure, both documented contributors to crash risk in drivers with a history of skin cancer.
• Consistent passive UV and visible-light attenuation beats sunglasses alone, which can be forgotten, scratched, or misaligned.
• Darker side and rear windows blunt the "sun flash" effect during turns, tree-lined roads, and sunrise/sunset driving — the worst triggering windows of the day.
• Passengers — including children and family members with the same condition — receive identical protection.
• Tint does not replace prescribed eyewear, medications, or follow-up care; it complements them by cutting environmental trigger load while you drive.

How to Get Your Melanoma / Skin Cancer Tint Exemption

MyEyeRx is a consultation-booking service: we connect patients with independent, U.S.-licensed physicians and optometrists who complete the medical portion of your state's window-tint exemption form. The clinical evaluation is done by the provider, not by MyEyeRx. Here's what the end-to-end process looks like.

1. 1

   Complete your questionnaire

   Tell us about your melanoma / skin cancer diagnosis, symptoms, current medications, and the state where your vehicle is registered. Free prequalification takes under 5 minutes.

2. 2

   Physician review & consultation

   A licensed U.S. physician or optometrist reviews your records and — where clinically appropriate — documents medical necessity on your state's exemption form. Typical turnaround is 24–48 hours.

3. 3

   Submit to your state & tint your vehicle

   We deliver the completed form and any supporting physician letter. You submit to your state DMV or state police (rules vary), then schedule your installer once the exemption is on file. Our state-by-state guide lists the exact form, processing agency, and VLT limit for your state.

Documentation Your Physician Will Need

You don't need all of this to start — our evaluating physician can request records as needed. But having these on hand speeds the turnaround and strengthens the application.

• A documented diagnosis of melanoma, squamous-cell carcinoma, basal-cell carcinoma, or high-risk precursor lesions (e.g. dysplastic nevi) from a licensed physician, ophthalmologist, optometrist, or specialist.
• A recent exam (within the last 12–24 months in most states — check your state guide for the exact window).
• A clinical note describing how melanoma, squamous-cell carcinoma, basal-cell carcinoma, or high-risk precursor lesions (e.g. dysplastic nevi) causes light sensitivity, UV vulnerability, glare intolerance, or related driving-safety impairment.
• Any current medications that increase photosensitivity and whether they are expected to be long-term.
• Your state's specific exemption form — our evaluating physician completes the medical portion; you submit it to your state DMV or state police.

Melanoma / Skin Cancer Tint Exemption FAQ

References & Further Reading

This article draws on the following authoritative sources. All links go to the primary publisher — none are affiliate or referral links. Last reviewed April 2026.

1. American Cancer Society — Melanoma Key Statistics — American Cancer Society
2. JAMA Ophthalmology — UV-A Protection of Automotive Window Glass — JAMA / American Medical Association
3. Skin Cancer Foundation — UV Protection in Cars — Skin Cancer Foundation
4. Butler & Fosko — Asymmetric Photodamage on the Driver Side — NIH / Journal of the American Academy of Dermatology